3 results
Approved WMOCompleted
To assess the clinical safety and feasibility of the MaMaLoc technique: a novel magnetic localisation technique for intra-operative lesion localisation.
Approved WMOCompleted
To demonstrate that treatment with drotrecogin alfa (activated) 24 mcg/kg/h administered as an intravenous infusion for 96 hours reduces 28 day all-cause mortality in adult patients with septic shock compared with placebo.
Approved WMOCompleted
To study whether hyqvia is as effective, safe and tolerable (or more tolerable) as IVIg.